GGrantIndex
Sort

16,300 grants matching fatty liver disease

HeartShare: Next-Generation Phenomics to Define Heart Failure Subtypes and Treatment Targets - Clinical Centers

$264,373
Julio Alonso Chirinos Medina · University Of Pennsylvania · U01 · FY2024 · HL

Pathogenic Role of Loss of Butyrate Producing Bacteria in Immune Dysregulation and Development of Alcoholic Liver Disease (ALD)

$264,183
Shirish S Barve · University Of Louisville · P50 · FY2022 · AA

Adipokine Signaling in Macrophages

$264,138
Ling Qi · Cornell University · R01 · FY2011 · DK

Adipokine Signaling in Macrophages

$264,138
Ling Qi · Cornell University · R01 · FY2012 · DK

The Endocannabinoid System in hepatic Injury and Fibrosis

$264,040
Robert F. Schwabe · Columbia University Health Sciences · R01 · FY2007 · DK

Homocysteine, Adiponectin, and Alcoholic Liver Disease

$263,989
Zhenyuan Song · University Of Illinois At Chicago · R01 · FY2013 · AA

Determining the influence of sex and gender in hepatocellular carcinoma risk and survival

$263,863
Nicole Elizabeth Rich · Ut Southwestern Medical Center · K08 · FY2024 · CA

Maternal Liver Disease and Fatty Acid Oxidation Defects

$263,843
Wake Forest University Health Sciences · R01 · FY2001 · DK

Microbiomics and Functional Genomics Core

$263,838
David Tevis Pride · University Of California, San Diego · P30 · FY2023 · DK

Microbiomics and Functional Genomics Core

$263,838
Robin Knight · University Of California, San Diego · P30 · FY2022 · DK

Cholestasis Reversal (Phase ll): Efficacy of lV Fish Oil

$263,803
Mark Puder · Boston Children'S Hospital · R01 · FY2009 · FD

Microbiomics and Functional Genomics Core

$263,699
Robin Knight · University Of California, San Diego · P30 · FY2021 · DK

Molecular and Cellular Basis of Obesity Core

$263,683
David A Bernlohr · University Of Minnesota · P30 · FY2012 · DK

A HIGH MAGNETIC FIELD MOSSBAUER INSTRUMENT

$263,676
Stephen P. Cramer · University Of California At Davis · S10 · FY2008 · RR

Determining the influence of sex and gender in hepatocellular carcinoma risk and survival

$263,648
Nicole Elizabeth Rich · Ut Southwestern Medical Center · K08 · FY2022 · CA

Determining the influence of sex and gender in hepatocellular carcinoma risk and survival

$263,548
Nicole Elizabeth Rich · Ut Southwestern Medical Center · K08 · FY2023 · CA

Growth regulation by the Fat signaling pathway

$263,533
Kenneth D Irvine · Rutgers, The State Univ Of N.J. · R01 · FY2014 · GM

Clinical utility of leptin therapy in syndromic forms of insulin resistance.

$263,476
Phillip Gorden · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2017 · DK

Project 4: Gut Microbiome - Host Interactions in Response to TCDD Exposure

$263,400
Syed A. Hashsham · Michigan State University · P42 · FY2014 · ES

SHP-regulation of Lipid and Lipoprotein Metabolism

$263,375
Li Wang · University Of Utah · R01 · FY2008 · DK

SHP-regulation of Lipid and Lipoprotein Metabolism

$263,375
Li Wang · University Of Utah · R01 · FY2009 · DK

Molecular Physiology of Hepatic Transport

$263,375
Richard M Green · Northwestern University At Chicago · R01 · FY2006 · DK

Purinergic Regulation of hepatocyte proliferation

$263,351
Sundararajah Thevananther · Baylor College Of Medicine · R01 · FY2008 · DK

Purinergic Regulation of hepatocyte proliferation

$263,351
Sundararajah Thevananther · Baylor College Of Medicine · R01 · FY2009 · DK

Growth regulation by the Fat signaling pathway

$263,271
Kenneth D Irvine · Rutgers, The State Univ Of N.J. · R01 · FY2012 · GM